Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus

Open access
Dale, Elena, Zhang, Hong, Leiser, Steven C, Xiao, Yixin, Lu, Dunguo, Yang, Charles R, Plath, Niels, Sanchez, Connie · 2014 · Journal of Psychopharmacology

Abstract

Vortioxetine, a novel antidepressant with multimodal action, is a serotonin (5-HT) 3 , 5-HT 7 and 5-HT 1D receptor antagonist, a 5-HT 1B receptor partial agonist, a 5-HT 1A receptor agonist and a 5-HT transporter (SERT) inhibitor. Vortioxetine has been shown to improve cognitive performance in several preclinical rat models and in patients with major depressive disorder. Here we investigated the mechanistic basis for these effects by studying the effect of vortioxetine on synaptic transmission, long-term potentiation (LTP), a cellular correlate of learning and memory, and theta oscillations in the rat hippocampus and frontal cortex. Vortioxetine was found to prevent the 5-HT-induced increase in inhibitory post-synaptic potentials recorded from CA1 pyramidal cells, most likely by 5-HT 3 receptor antagonism. Vortioxetine also enhanced LTP in the CA1 region of the hippocampus. Finally, vortioxetine increased fronto-cortical theta power during active wake in whole animal electroencephalographic recordings. In comparison, the selective SERT inhibitor escitalopram showed no effect on any of these measures. Taken together, our results indicate that vortioxetine can increase pyramidal cell output, which leads to enhanced synaptic plasticity in the hippocampus. Given the central role of the hippocampus in cognition, these findings may provide a cellular correlate to the observed preclinical and clinical cognition-enhancing effects of vortioxetine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881114543719

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Serotonin (5-HT) increased frequency and amplitude of spontaneous inhibitory post-synaptic currents (sIPSCs), but not miniature inhibitory post-synaptic currents (mIPSCs), recorded from hippocampal CA1 pyramidal cells. (a1), (b1) Representative traces of sIPSCs (a1) and mIPSCs (b1) recorded from a CA1 pyramidal cell before and after local application of 5-HT (100 µM for 500 ms). mIPSCs were recorded in the presence of 1 µM tetrodotoxin (TTX). (a2), (a3) Serotonin (5-HT) transiently increased the frequency ((a2), ****p<0.001, **p=0.0078, *p=0.0361, one-way analysis of variance (ANOVA) with Dunnett’s multiple comparisons test vs baseline) and amplitude ((a3), ****p<0.001, *p=0.0235, one-way ANOVA with Dunnett’s multiple comparisons test vs baseline) of sIPSCs. The largest increase was observed in the first 15 s after 5-HT application and the response to 5-HT was largely desensitized after 60 s. Bars represent the mean±standard error of the mean (SEM) of recordings from 10 cells. (b2), (b3) 5-HT had no effect on mIPSC frequency (b2) or amplitude (b3) (p>0.05, paired Student’s t-test). Bars represent the mean±SEM of 60 s recordings from four cells.
Figure 1. Serotonin (5-HT) increased frequency and amplitude of spontaneous inhibitory post-synaptic currents (sIPSCs), but not miniature inhibitory post-synaptic currents (mIPSCs), recorded from hippocampal CA1 pyramidal cells. (a1), (b1) Representative traces of sIPSCs (a1) and mIPSCs (b1) recorded from a CA1 pyramidal cell before and after local application of 5-HT (100 µM for 500 ms). mIPSCs were recorded in the presence of 1 µM tetrodotoxin (TTX). (a2), (a3) Serotonin (5-HT) transiently increased the frequency ((a2), ****p<0.001, **p=0.0078, *p=0.0361, one-way analysis of variance (ANOVA) with Dunnett’s multiple comparisons test vs baseline) and amplitude ((a3), ****p<0.001, *p=0.0235, one-way ANOVA with Dunnett’s multiple comparisons test vs baseline) of sIPSCs. The largest increase was observed in the first 15 s after 5-HT application and the response to 5-HT was largely desensitized after 60 s. Bars represent the mean±standard error of the mean (SEM) of recordings from 10 cells. (b2), (b3) 5-HT had no effect on mIPSC frequency (b2) or amplitude (b3) (p>0.05, paired Student’s t-test). Bars represent the mean±SEM of 60 s recordings from four cells.CC BY-NC · PubMed Central
Figure 2. Vortioxetine blocked the serotonin (5-HT)-induced increase in spontaneous inhibitory post-synaptic currents (sIPSCs). (a) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to 5-HT before (left) and after 15 min application of 20 µM vortioxetine (right). (b1), (c1) Vortioxetine blocked the 5-HT induced increase in sIPSC frequency ((b1), **p=0.0073, paired Student’s t-test) and amplitude ((c1), **p=0.0066, paired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bars represent the mean±standard error of the mean (SEM) of sIPSCs from 15 cells. (b2), (c2) Averaged cumulative probability plots of sIPSC inter-event interval (b2) and amplitude (c2) for 5-HT alone and 5-HT+vortioxetine. Data for these graphs were derived from 60 s of continuous recordings. Each data point represents the mean from 15 cells. Vortioxetine significantly increased the inter-event interval time in 14/15 cells and shifted amplitudes of sIPSCs to lower values in 13/15 cells after 5-HT application (p<0.05, Kolmogorov-Smirnov (K-S) test).
Figure 2. Vortioxetine blocked the serotonin (5-HT)-induced increase in spontaneous inhibitory post-synaptic currents (sIPSCs). (a) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to 5-HT before (left) and after 15 min application of 20 µM vortioxetine (right). (b1), (c1) Vortioxetine blocked the 5-HT induced increase in sIPSC frequency ((b1), **p=0.0073, paired Student’s t-test) and amplitude ((c1), **p=0.0066, paired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bars represent the mean±standard error of the mean (SEM) of sIPSCs from 15 cells. (b2), (c2) Averaged cumulative probability plots of sIPSC inter-event interval (b2) and amplitude (c2) for 5-HT alone and 5-HT+vortioxetine. Data for these graphs were derived from 60 s of continuous recordings. Each data point represents the mean from 15 cells. Vortioxetine significantly increased the inter-event interval time in 14/15 cells and shifted amplitudes of sIPSCs to lower values in 13/15 cells after 5-HT application (p<0.05, Kolmogorov-Smirnov (K-S) test).CC BY-NC · PubMed Central
Figure 3. Escitalopram had no effect on serotonin (5-HT) increase of spontaneous inhibitory post-synaptic currents (sIPSCs). (a1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to 5-HT before (left) and after 15 min perfusion with 10 µM escitalopram (right). (a2), (a3) Escitalopram did not change the 5-HT response on sIPSC frequency (a2) or amplitude (a3) (p>0.05, paired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bar graphs represent the mean±standard error of the mean (SEM) from six cells.
Figure 3. Escitalopram had no effect on serotonin (5-HT) increase of spontaneous inhibitory post-synaptic currents (sIPSCs). (a1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to 5-HT before (left) and after 15 min perfusion with 10 µM escitalopram (right). (a2), (a3) Escitalopram did not change the 5-HT response on sIPSC frequency (a2) or amplitude (a3) (p>0.05, paired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bar graphs represent the mean±standard error of the mean (SEM) from six cells.CC BY-NC · PubMed Central
Figure 4. The serotonin (5-HT)3 receptor agonist m-chlorophenylbiguanide hydrochloride (m-CPBG) transiently increased spontaneous inhibitory post-synaptic currents (sIPSCs) and vortioxetine blocked the m-CPBG effect. (a1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to two applications of the 5-HT3 receptor agonist m-CPBG. In most of the responding cells, the effect of m-CPBG was not repeatable after various application intervals (compare right and left traces). (a2), (a3) The second application of m-CPBG did not induce the same increase in sIPSC frequency ((a2), *p=0.031, paired Student’s t-test) or amplitude ((a3), *p=0.024, paired Student’s t-test) as the first application. Bar graphs represent the mean±standard error of the mean (SEM) from 11 cells. Because of strong desensitization of m-CPBG responses, the effect of vortioxetine was tested in a separate set of cells. (b1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to m-CPBG in the presence of 20 µM vortioxetine. (b2), (b3) Pre-treatment with vortioxetine blocked the m-CPBG increase in sIPSC frequency ((b2), *p=0.034, unpaired Student’s t-test) and amplitude ((b3), *p=0.028, unpaired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bar graphs represent the mean±SEM from 11 cells for the m-CPBG only condition and from nine cells for the m-CPBG + vortioxetine condition.
Figure 4. The serotonin (5-HT)3 receptor agonist m-chlorophenylbiguanide hydrochloride (m-CPBG) transiently increased spontaneous inhibitory post-synaptic currents (sIPSCs) and vortioxetine blocked the m-CPBG effect. (a1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to two applications of the 5-HT3 receptor agonist m-CPBG. In most of the responding cells, the effect of m-CPBG was not repeatable after various application intervals (compare right and left traces). (a2), (a3) The second application of m-CPBG did not induce the same increase in sIPSC frequency ((a2), *p=0.031, paired Student’s t-test) or amplitude ((a3), *p=0.024, paired Student’s t-test) as the first application. Bar graphs represent the mean±standard error of the mean (SEM) from 11 cells. Because of strong desensitization of m-CPBG responses, the effect of vortioxetine was tested in a separate set of cells. (b1) Representative sIPSCs recorded from a CA1 pyramidal neuron in response to m-CPBG in the presence of 20 µM vortioxetine. (b2), (b3) Pre-treatment with vortioxetine blocked the m-CPBG increase in sIPSC frequency ((b2), *p=0.034, unpaired Student’s t-test) and amplitude ((b3), *p=0.028, unpaired Student’s t-test). Frequency and amplitude were normalized to the mean value during the 30 s of recordings prior to 5-HT application. Bar graphs represent the mean±SEM from 11 cells for the m-CPBG only condition and from nine cells for the m-CPBG + vortioxetine condition.CC BY-NC · PubMed Central
Figure 5. Vortioxetine enhanced theta burst long-term potentiation (LTP) in hippocampal slices. Representative traces of field excitatory post-synaptic potential (fEPSP) recordings from vehicle-treated, vortioxetine-treated and escitalopram-treated slices are shown on top of the graph. Each trace is the mean of five sweeps taken either immediately before (dashed line marked with (1) or 50 min after (solid line marked with (2)) theta-burst stimulation (TBS). TBS, marked with an arrow in the time course graph, induced a long-lasting increase in the slopes of fEPSPs. For each time point, fEPSP slopes were calculated from either vehicle-treated (n=17 slices from 12 animals), vortioxetine-treated (n=14 from nine animals) or escitalopram-treated slices (n=5 slices from four animals) and expressed as % of baseline. Data are shown as the mean±standard error of the mean (SEM). Perfusion of hippocampal slices with vortioxetine for 30 min prior to TBS increased LTP without affecting baseline transmission (p=0.0017 vortioxetine vs vehicle, two-way analysis of variance (ANOVA) F(2,38)=7.548)). Escitalopram had no effect on LTP (p>0.05).
Figure 5. Vortioxetine enhanced theta burst long-term potentiation (LTP) in hippocampal slices. Representative traces of field excitatory post-synaptic potential (fEPSP) recordings from vehicle-treated, vortioxetine-treated and escitalopram-treated slices are shown on top of the graph. Each trace is the mean of five sweeps taken either immediately before (dashed line marked with (1) or 50 min after (solid line marked with (2)) theta-burst stimulation (TBS). TBS, marked with an arrow in the time course graph, induced a long-lasting increase in the slopes of fEPSPs. For each time point, fEPSP slopes were calculated from either vehicle-treated (n=17 slices from 12 animals), vortioxetine-treated (n=14 from nine animals) or escitalopram-treated slices (n=5 slices from four animals) and expressed as % of baseline. Data are shown as the mean±standard error of the mean (SEM). Perfusion of hippocampal slices with vortioxetine for 30 min prior to TBS increased LTP without affecting baseline transmission (p=0.0017 vortioxetine vs vehicle, two-way analysis of variance (ANOVA) F(2,38)=7.548)). Escitalopram had no effect on LTP (p>0.05).CC BY-NC · PubMed Central
Figure 6. Vortioxetine increased frontal cortical theta power in in vivo electroencephalography (EEG) recordings. (a1) Total relative theta power are shown for each treatment for every 15 min from 0–180 min postdose. A treatment effect was observed for vortioxetine (VOR), but not escitalopram (p=0.0226, one-way analysis of variance (ANOVA) F(65,497)=1.4180). (a2) Pharmacologically-induced changes in EEG recordings were quantified by averaging the 10 s bins constituting 15–75 min before (baseline) and 45–90 min post-drug treatment. Theta power was expressed as the percentage change from baseline. Bar graphs represent the mean±standard error of the mean (SEM) (n=9 rats per condition). A negative value indicates a decrease in EEG power from baseline. Vortioxetine at 5.0 and 10 mg/kg significantly increased theta power (*p<0.05, post-dose versus vehicle, one-way analysis of variance (ANOVA) with least significant difference (LSD) post-hoc comparison). Escitalopram at 2.0 mg/kg had no effect on theta power.
Figure 6. Vortioxetine increased frontal cortical theta power in in vivo electroencephalography (EEG) recordings. (a1) Total relative theta power are shown for each treatment for every 15 min from 0–180 min postdose. A treatment effect was observed for vortioxetine (VOR), but not escitalopram (p=0.0226, one-way analysis of variance (ANOVA) F(65,497)=1.4180). (a2) Pharmacologically-induced changes in EEG recordings were quantified by averaging the 10 s bins constituting 15–75 min before (baseline) and 45–90 min post-drug treatment. Theta power was expressed as the percentage change from baseline. Bar graphs represent the mean±standard error of the mean (SEM) (n=9 rats per condition). A negative value indicates a decrease in EEG power from baseline. Vortioxetine at 5.0 and 10 mg/kg significantly increased theta power (*p<0.05, post-dose versus vehicle, one-way analysis of variance (ANOVA) with least significant difference (LSD) post-hoc comparison). Escitalopram at 2.0 mg/kg had no effect on theta power.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Research works printed but not linked: 4

  1. Adell A, 2010, IDrugs, 13, 900
  2. Maire M, 2013, J Cogn Behav Psychother, 13, 133
  3. Tokarski K, 2011, J Physiol Pharmacol, 62, 535
  4. Westrich L, 2012, Int J Psychiatry Clin Pract, 16, 47

Cited by

See all 93

Metadata

Authors
Dale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C.
Affiliations
  • Lundbeck Research USA, Paramus, NJ, USA
  • Shanghai Chempartner Co. Ltd., Shanghai, China
  • Lundbeck (Denmark) (DK)
Corresponding author
Dale, Elena
Venue
Journal of Psychopharmacology
Published
2014-08-13
Volume
28
Issue
10
Pages
891-902
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2135657370
Cited by
93
References
66
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 14 · 2014: 2
FWCI
9.94
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
vortioxetine, serotonin receptors, 5-HT3 receptor antagonism, synaptic plasticity, long-term potentiation, CA1 pyramidal neurons, inhibitory postsynaptic potentials, theta oscillations, serotonin transporter inhibition, escitalopram, cognitive enhancement, major depressive disorder, antidepressants
MeSH terms
Vortioxetine, Animals, Antidepressive Agents, Frontal Lobe, Synaptic Transmission, Neuronal Plasticity, Piperazines, Serotonin, Serotonin Antagonists, Sulfides, Theta Rhythm, Citalopram, Pyramidal Cells, Rats, Inhibitory Postsynaptic Potentials, CA1 Region, Hippocampal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. https://app.cochat.ai/papers/10.1177/0269881114543719
The paper
Dale, E., Zhang, H., Leiser, S. C., Xiao, Y., Lu, D., Yang, C. R., Plath, N., & Sanchez, C. (2014). Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. Journal of Psychopharmacology. https://doi.org/10.1177/0269881114543719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.